H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to humans.
Scientists at UNC Charlotte and MIT used high-performance computational modeling to analyze thousands of viral protein-antibody interactions, revealing a decline in immune response effectiveness. Their research suggests that H5N1 mutations may soon enable human-to-human transmission, raising pandemic concerns. The virus has already spread among wild birds, poultry, cattle, and even farmworkers, emphasizing the need for swift vaccine development.
H5N1's Rapid Evolution Poses a Growing Threat
A research team at the University of North Carolina at Charlotte has used advanced computational modeling to study how the H5N1 bird flu virus interacts with the immune system. Their findings show that the virus is evolving in ways that help it evade immune defenses, whether from past infection or vaccination, in mammals.
Published on March 17 in eBioMedicine (a journal within The Lancet family), the study highlights urgent concerns. As avian influenza continues to spread globally, it poses not only a serious risk to agriculture but also an increasing threat to human health.
Worsening Antibody Affinity Raises Concerns
The researchers found a clear trend: antibodies are becoming less effective against newer strains of H5N1. This "worsening antibody affinity" suggests that future versions of the virus may be even more difficult for the immune system to recognize and fight, raising the risk of transmission to and among humans.
The study's lead author is Colby T. Ford, Ph.D., a visiting scholar in data science at UNC Charlotte's CIPHER center and founder of Tuple, LLC, a biotechnology consulting firm based in Charlotte.
Crucially, Ford explains, this rapid adaptation means that "if one makes an H5N1 vaccine with a previous vaccine candidate virus, the vaccine will have less efficacy, based on our measurements of how much the virus has evolved in recent years" As such, the team's research approach provides guidance for keeping pace with a rapidly adapting viral threat.
The team from UNC Charlotte's Department of Bioinformatics and Genomics includes students Shirish Yasa, Khaled Obeid, and Sayal Guirales-Medrano, led by Bioinformatics Assistant Professor Richard Allen White III, Ph.D., and CIPHER Co-Director Daniel Janies, Ph.D. who is the Carol Grotnes Belk Distinguished Professor of Bioinformatics and Genomics. The UNC Charlotte team collaborated with researchers from the Massachusetts Institute of Technology: Rafael Jaimes III, Ph.D., and Phillip J. Tomezsko, Ph.D.
Antigenic Drift and Increased Zoonotic Risk
By examining the virus' rampant host-shifting and recent mutations comprehensively, researchers find "the continuous transmission of H5N1 from birds to mammals and the increase in strains with immuno-evasive HA in mammals sampled over time suggest that antigenic drift is a source of zoonotic risk."
In the paper, "Large-scale computational modeling of H5 influenza variants against HA1-neutralising antibodies," the UNC Charlotte research team shares their results from analysis of 1,804 viral protein-host antibody comparisons. The experiments consisted of current hemagglutinin domain 1 viral proteins computationally bound in physics models to neutralizing antibodies obtained from infected hosts and vaccine recipients from 1996 to 2018.
Computational Modeling Reveals Alarming Trends
Using high-performance computational modeling, CIPHER researchers documented "a trend of weakening binding affinity of a wide variety of existing antibodies, collected from vaccinated and or infected hosts, against H5 viral isolates over time."
Due to the public health importance, the findings were available via preprint publication in July 2024 prior to successful peer review. Due to the computational tools they had assembled during the SARS-CoV-2 pandemic, the team was able to complete this work on H5N1 just three months after the first reported cow-to-human transmission of H5N1, which was reported in a farmworker in Texas.
In assessing the possible pandemic risk spurred by H5 bird flu spread and mutation, global researchers agree that "the avian virus (remains) high on lists of potential pandemic agents," as reported in Science in December 2024.
H5N1 Cases Surge in Mammals and Poultry
As of this writing, no human-to-human transmission has been reported. However, cattle in at least 17 states have tested positive for H5N1 in addition to millions of cases among wild birds, small mammals, commercial chickens, and other flocks. Between January 2022 and March 2025, the Centers for Disease Control reported:
- 12,510 outbreaks among wild birds in the U.S.
- 51 jurisdictions with bird flu among wild birds.
- 166,417,923 poultry affected
- 70 human cases of H5N1, one fatal, in the U.S.
The H5N1 virus, according to the World Health Organization, has killed 466 people worldwide since January 2003.
Speed Crucial to Combat a Fast-Adapting Virus
Vaccines, many experts say, will likely be a crucial tool in controlling a bird flu pandemic, as mutations of viral lineages adapt to new mammal hosts.
In eBioMedicine, the research team from Charlotte writes that their findings "indicate that the virus has potential to move from epidemic to pandemic status in the near future."
The study – along with other research that confirms worsening antibody binding over time alongside increased avian-to-mammalian transmission – indicates "there is an impending danger to human health for highly pathogenic strains of H5 influenza that can infect avian and mammalian livestock and jump to humans."
Avian Influenza can already be considered a pandemic among wild and domesticated animals due to the virus' pervasive spread across geography and species. Likewise, the spread of H5N1 from wild birds to chickens, dairy cattle, and farm workers illustrates the opportunism of infections across species.
Now, UNC Charlotte's computational modeling results "specifically assert that the worsening trend of the antibody performance along with the already present animal pandemic is a cause for concern for an eventual human pandemic."
Computational Modeling: A Key Tool for Preparedness
Further, the authors write that high-performance computing – which in this case included AI-based protein folding and physics-based simulations of viral protein-antibody interactions – provides rapid and reliable results to inform leaders in preparedness.
Janies, in a recent interview, explained the utility of computational modeling as a means of understanding viral mutation as well as predictive thinking concerning how a virus is evolving.
High-performance computational modeling, Janies said, is a pathway for "chipping away at multiple angles of biological variation at speed and scale" to "tune our intuition to the right approaches" for vaccine efficacy and infection control as viruses evolve.
Reference: "Large-scale computational modelling of H5 influenza variants against HA1-neutralising antibodies" by Colby T. Ford, Shirish Yasa, Khaled Obeid, Rafael Jaimes, Phillip J. Tomezsko, Sayal Guirales-Medrano, Richard Allen White and Daniel Janies, 17 March 2025, eBioMedicine.
DOI: 10.1016/j.ebiom.2025.105632
The protein modeling research on H5N1 viral lineages conducted at UNC Charlotte was funded by an Ignite grant from the UNC Charlotte Division of Research. Research used genetic data and metadata from GISAID, the Global Initiative on Sharing All Influenza Data, and the United States National Institutes of Health's GenBank.
News
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]















